Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study

NCT01305122 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT01305122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01305122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2011
Completion date
October 21, 2018
Enrollment
112 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

oms grade ii glioma